Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891783064> ?p ?o ?g. }
- W2891783064 endingPage "2369" @default.
- W2891783064 startingPage "2369" @default.
- W2891783064 abstract "Protein kinases have emerged as crucial targets for cancer therapy over the last decades. Since 2001, 40 and 39 kinase inhibitors have been approved by FDA and EMA, respectively, and the majority are antineoplastic drugs. Morevoer, many candidates are currently in clinical trials. We previously reported a small library of 4-aminoimidazole and 2-aminothiazole derivatives active as Src family kinase (SFK) inhibitors. Starting from these results, we decided to perform an optimization study applying a mix and match strategy to identify a more potent generation of 4-aminoimidazoles. Firstly, a computational study has been performed, then compounds showing the best predicted docking scores were synthesized and screened in a cell-free assay for their SFK inhibitory activity. All the new chemical entities showed IC50s in the nanomolar range, with 2⁻130 fold increased activities compared to the previously reported inhibitors. Finally, the most active compounds have been tested on three cancer cell lines characterized by Src hyperactivation. Compounds 4k and 4l showed an interesting antiproliferative activity on SH-SY5Y neuroblastoma (NB) cell line. In this assay, the compounds resulted more potent than dasatinib, a tyrosine kinase inhibitor approved for the treatment of leukemias and in clinical trials for NB." @default.
- W2891783064 created "2018-09-27" @default.
- W2891783064 creator A5008783082 @default.
- W2891783064 creator A5018270046 @default.
- W2891783064 creator A5020441048 @default.
- W2891783064 creator A5032880429 @default.
- W2891783064 creator A5038882241 @default.
- W2891783064 creator A5046402166 @default.
- W2891783064 creator A5056135019 @default.
- W2891783064 creator A5068941229 @default.
- W2891783064 creator A5083762891 @default.
- W2891783064 date "2018-09-17" @default.
- W2891783064 modified "2023-10-18" @default.
- W2891783064 title "Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors" @default.
- W2891783064 cites W1608710587 @default.
- W2891783064 cites W1840208272 @default.
- W2891783064 cites W1962270087 @default.
- W2891783064 cites W1964396270 @default.
- W2891783064 cites W1966285532 @default.
- W2891783064 cites W1975992482 @default.
- W2891783064 cites W1976118830 @default.
- W2891783064 cites W1985588649 @default.
- W2891783064 cites W1990524359 @default.
- W2891783064 cites W1991795177 @default.
- W2891783064 cites W1992945955 @default.
- W2891783064 cites W2002207761 @default.
- W2891783064 cites W2008589980 @default.
- W2891783064 cites W2009423060 @default.
- W2891783064 cites W2025535065 @default.
- W2891783064 cites W2030205108 @default.
- W2891783064 cites W2031168104 @default.
- W2891783064 cites W2044333356 @default.
- W2891783064 cites W2048633418 @default.
- W2891783064 cites W2054466658 @default.
- W2891783064 cites W2056017011 @default.
- W2891783064 cites W2058832210 @default.
- W2891783064 cites W2059955037 @default.
- W2891783064 cites W2062420449 @default.
- W2891783064 cites W2077804275 @default.
- W2891783064 cites W2086286404 @default.
- W2891783064 cites W2092606584 @default.
- W2891783064 cites W2102377211 @default.
- W2891783064 cites W2122279303 @default.
- W2891783064 cites W2138072853 @default.
- W2891783064 cites W2138778824 @default.
- W2891783064 cites W2145442626 @default.
- W2891783064 cites W2163239556 @default.
- W2891783064 cites W2916183363 @default.
- W2891783064 doi "https://doi.org/10.3390/molecules23092369" @default.
- W2891783064 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6225123" @default.
- W2891783064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30227617" @default.
- W2891783064 hasPublicationYear "2018" @default.
- W2891783064 type Work @default.
- W2891783064 sameAs 2891783064 @default.
- W2891783064 citedByCount "4" @default.
- W2891783064 countsByYear W28917830642020 @default.
- W2891783064 countsByYear W28917830642021 @default.
- W2891783064 countsByYear W28917830642022 @default.
- W2891783064 crossrefType "journal-article" @default.
- W2891783064 hasAuthorship W2891783064A5008783082 @default.
- W2891783064 hasAuthorship W2891783064A5018270046 @default.
- W2891783064 hasAuthorship W2891783064A5020441048 @default.
- W2891783064 hasAuthorship W2891783064A5032880429 @default.
- W2891783064 hasAuthorship W2891783064A5038882241 @default.
- W2891783064 hasAuthorship W2891783064A5046402166 @default.
- W2891783064 hasAuthorship W2891783064A5056135019 @default.
- W2891783064 hasAuthorship W2891783064A5068941229 @default.
- W2891783064 hasAuthorship W2891783064A5083762891 @default.
- W2891783064 hasBestOaLocation W28917830641 @default.
- W2891783064 hasConcept C108636557 @default.
- W2891783064 hasConcept C159110408 @default.
- W2891783064 hasConcept C184235292 @default.
- W2891783064 hasConcept C185592680 @default.
- W2891783064 hasConcept C2779536868 @default.
- W2891783064 hasConcept C2779976819 @default.
- W2891783064 hasConcept C41685203 @default.
- W2891783064 hasConcept C42362537 @default.
- W2891783064 hasConcept C502942594 @default.
- W2891783064 hasConcept C54355233 @default.
- W2891783064 hasConcept C55493867 @default.
- W2891783064 hasConcept C62478195 @default.
- W2891783064 hasConcept C71924100 @default.
- W2891783064 hasConcept C81885089 @default.
- W2891783064 hasConcept C86803240 @default.
- W2891783064 hasConcept C98274493 @default.
- W2891783064 hasConceptScore W2891783064C108636557 @default.
- W2891783064 hasConceptScore W2891783064C159110408 @default.
- W2891783064 hasConceptScore W2891783064C184235292 @default.
- W2891783064 hasConceptScore W2891783064C185592680 @default.
- W2891783064 hasConceptScore W2891783064C2779536868 @default.
- W2891783064 hasConceptScore W2891783064C2779976819 @default.
- W2891783064 hasConceptScore W2891783064C41685203 @default.
- W2891783064 hasConceptScore W2891783064C42362537 @default.
- W2891783064 hasConceptScore W2891783064C502942594 @default.
- W2891783064 hasConceptScore W2891783064C54355233 @default.
- W2891783064 hasConceptScore W2891783064C55493867 @default.
- W2891783064 hasConceptScore W2891783064C62478195 @default.
- W2891783064 hasConceptScore W2891783064C71924100 @default.